USPTO serial 79292986
OPERATING SYSTEM OF LIFE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 21, 2023
- Examiner
- GRIFFIN, JAMES
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OPERATING SYSTEM OF LIFE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline L. Patt
Jacqueline L. Patt Markery Law LLCPO Box 84150Gaithersburg, MD 20833-4150United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technology; cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical research; all of the foregoing excluding vaccines and RNA-based therapeutics | ACTIVE | — |
| 005 | Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Diagnostic preparations for medical and veterinary purposes; Cell preparations for medical use in drug screening; Cell preparations for genetic testing and screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical or diagnostic use; Tissue culture media, growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplements | ACTIVE | — |
| 009 | Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; magnetic cell separation equipment, namely, apparatus for the separation of cell populations for medical or clinical use; all of the foregoing excluding vaccines and RNA-based therapeutics | ACTIVE | — |
| 029 | Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not live | ACTIVE | — |
| 040 | Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and/or veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not live; all of the foregoing excluding vaccines and RNA-based therapeutics | ACTIVE | — |
| 042 | Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services for scientific, research, clinical, therapeutic and manufacturing purposes; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; all of the foregoing excluding vaccines and RNA-based therapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bit Bio Limited
- Other trademarks owned by Bit Bio Limited
- Other trademarks owned by Bit Bio Limited
- Other trademarks owned by Bit Bio Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 029
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named OPERATING SYSTEM OF LIFE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 6, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 6, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 6, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 6, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 8, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 22, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 22, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 21, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 21, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 21, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jan 12, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jan 12, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Sep 11, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 24, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 24, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 25, 2021 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2021 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Sep 13, 2021 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Sep 13, 2021 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Jun 9, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 18, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 18, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2021 | ISMR | WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST | — |
| Apr 9, 2021 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Apr 9, 2021 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Mar 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 20, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 5, 2021 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Dec 7, 2020 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 9, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |